NASDAQ:RNA | Income Statement | Atrium Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2025-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$3M$15.34M$25.62M-$22.62M$2.43M-$20.19M-$1.18-$1.1817,106,00017,106,000
2026-03-31$19.64M$16.66M$36.92M-$17.28M$647,000.00-$16.63M-$0.97-$0.9717,105,64317,105,643
2025-06-30$3.85M$13.29M$16.71M-$12.86M-$15,000.00-$12.88M-$0.75-$0.7517,106,00017,106,000
2025-03-31$1.57M$6.94M$9.03M-$7.45M$3,000.00-$7.45M-$0.44-$0.4417,105,64317,105,643

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.